City of Hope’s Alvarnas: Payers Must Recognize Cancer Care Is Different
April 17th 2022Joseph Alvarnas, MD, vice president of government affairs at City of Hope and chief clinical adviser of AccessHope in Duarte, California, spoke March 4 at the closing session of the Association for Community Cancer Centers (ACCC) Annual Meeting & Cancer Business Summit in Washington, DC.
Read More
Dr David Penberthy on ACCC Presidential Theme, Discussions for Next Year’s Meeting
March 10th 2022David Penberthy, MD, MBA, medical director of radiation oncology at Southside Regional Medical Center, discusses his theme as president-elect of the Association of Community Cancer Centers (ACCC) and what initiatives and discussions he looks forward to addressing over the next year.
Watch
Comprehensive Cancer Care Adds Value—the Challenge Is Paying for It, ACCC Survey Finds
March 5th 2022A session moderated by the president of the Association of Community Cancer Centers (ACCC) examined the business case for having oncology pharmacists and oncology social workers on community cancer care teams.
Read More
In Survivorship Care, Many Models for Communication and Value
March 3rd 2022The session opened the 48th Annual Meeting and Cancer Center Business Summit, which is the first in-person meeting in 2 years for the Association of Community Cancer Centers. The meeting is taking place March 2-4 in Washington, DC.
Read More
ACCC Presents Survey Responses on Adoption of Bispecific Antibodies
January 2nd 2022ACCC created a survey to better understand multidisciplinary cancer providers’ experiences with bispecific antibodies, with a focus on experiences with blinatumomab. Results of the survey were presented in an abstract during the 2021 American Society of Hematology Annual Meeting & Exposition.
Read More
Pricing, Payment Reform, and Politics Are Inextricably Linked in Cancer Care
April 9th 2021On day 2 of this year’s Community Oncology Conference, a panel of government and health policy experts gathered to discuss the hot-button issue of political influence on cancer policy and the damage community oncology has suffered this past year.
Read More
The National Institutes of Health's (NIH) “All of Us” research project was spotlighted for its potential to explain racial disparities due to coronavirus disease 2019 (COVID-19); the FDA has told Cool Clouds Distribution to stop selling its fruite-flavored e-cigarettes (e-cigs); the American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) partner to promote minority participation in cancer treatment trials.
Read More
Ali McBride, PharmD, MS, BCOP, Becomes ACCC President 2019-2020
March 27th 2019Ali McBride, PharmD, MS, BCOP, was named 2019-2020 president of the Association of Community Cancer Centers (ACCC) during its 45th Annual Meeting & Cancer Center Business Summit on March 22, 2019, in Washington, DC. McBride is the clinical coordinator of hematology/oncology at The University of Arizona Cancer Center.
Read More
ACCC Publication Offers Insight for Incorporating Immunotherapies Into Practice
February 4th 2019The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties.
Read More
ACCC Survey Identifies Barriers to Cancer Program Growth
January 16th 2019Results from the Association of Community Cancer Centers' (ACCC's) ninth annual Trending Now in Cancer Care survey revealed how cancer programs across the country are being impacted by different healthcare stakeholders.
Read More